CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells
(Q78404465)
scientific article published on 01 November 2002
scientific article published on 01 November 2002
Language:
Current Data About
CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells
other details
| description | scientific article published on 01 November 2002 |
External Links
| (P356) |
10.4049/JIMMUNOL.169.9.4897
|
| (P698) |
12391201
|